Plant ID: NPO25682
Plant Latin Name: Acorus calamus
Taxonomy Genus: Acorus
Taxonomy Family: Acoraceae
NCBI TaxonomyDB:
4465
Plant-of-the-World-Online:
n.a.
Abortifacient; Anodyne; Antirheumatic; Aphrodisiac; Aromatic; Carminative; Diaphoretic; Emmenagogue; Febrifuge; Hallucinogenic; Homeopathy; Odontalgic; Sedative; Stimulant; Stomachic; Tonic; Vermifuge
Turkey; Indonesia; Italy; South Africa; Lithuania; Finland; India; China; Greece; Thailand; Bulgaria
TSHR; | |
MAPK1; | |
CA2; CA3; CA14; CA5A; CA6; CA12; CA9; CA1; CA7; | |
HMGCR; | |
MMP12; MMP2; | |
TP53; | |
MAPT; LMNA; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Oxidoreductase | HMGCR | HMG-CoA reductase | P04035 | CHEMBL402 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.647E-10 | 4.482E-07 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9, MMP12, MMP2, TP53 |
BP | GO:0065007; biological regulation | GO:0030641; regulation of cellular pH | 3.082E-06 | 4.194E-03 | CA2, CA7, MAPK1, TP53 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.375E-06 | 4.313E-03 | CA2, CA7 |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 3.565E-06 | 4.313E-03 | HMGCR, MAPT, TP53 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 6.746E-06 | 6.120E-03 | CYP1A2, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.424E-24 | 3.101E-20 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.985E-19 | 2.161E-15 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.262E-17 | 6.868E-14 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.684E-05 | 1.265E-02 | CYP1A2, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.684E-05 | 1.265E-02 | CA1, CA2 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 7.381E-05 | 4.121E-02 | SMN1, SMN2 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 8.718E-05 | 4.630E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 5.052E-24 | 6.365E-22 | CA12, CA1, CA3, CA2, CA5A, CA7, CA6, CA9, CA14 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 1.037E-05 | 6.530E-04 | MMP2, MAPK1, TP53 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 5.446E-05 | 2.287E-03 | CA2, HMGCR, CYP3A4 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 4.071E-04 | 8.801E-03 | LMNA, MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 4.191E-04 | 8.801E-03 | MAPK1, TP53 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.191E-04 | 8.801E-03 | CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 2.228E-03 | 1.662E-02 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05218 | Melanoma | 2.498E-03 | 1.662E-02 | MAPK1, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 2.638E-03 | 1.662E-02 | MAPK1, TP53 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.638E-03 | 1.662E-02 | CYP1A2, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |